Skip to main content
YDES logo
YDES
(NASDAQ)
YD Bio Limited
$7.43-- (--)
Loading... - Market loading

YD Bio (YDES) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

YD Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
YD Bio Limited income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.510.350.360.000.00
Cost of Revenue0.360.20-0.230.000.00
Gross Profit0.160.150.130.000.00
Operating Expenses
Research & Development0.490.000.000.000.00
Selling, General & Administrative1.130.160.181.720.34
Operating Expenses1.620.160.181.720.34
Operating Income-1.46-0.01-0.04-1.72-0.34
Other Income/Expense
Interest Income0.010.000.000.000.00
Interest Expense0.000.000.000.000.00
Other Income/Expense0.060.030.0610.43-2.19
Income
Income Before Tax-1.390.02-0.058.70-2.54
Income Tax Expense0.030.000.000.000.00
Net Income-1.410.01-0.058.70-2.54
Net Income - Continuous Operations-1.410.013.798.70-2.54
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-1.360.02-0.048.70-2.54
EBIT-1.460.02-0.050.000.00
Depreciation & Amortization0.100.000.000.000.00
Earnings Per Share
Basic EPS-66.00--1.00-
Diluted EPS-1.00--1.00-
Basic Shares Outstanding0.0070.101.0514.6314.63
Diluted Shares Outstanding0.0070.101.0514.6314.63

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.